Author | Elisabeth I. Heath, MD, FACP | OncLive

Author | Elisabeth I. Heath, MD, FACP

Articles

Dr. Heath on Developments in Nonmetastatic CRPC

May 13, 2020

Video

Elisabeth I. Heath, MD, FACP, discusses developments in nonmetastatic castration-resistant prostate cancer (CRPC).

Dr. Heath on Remaining Challenges in Nonmetastatic CRPC

January 23, 2020

Video

Elisabeth I. Heath, MD, FACP, discusses a remaining challenge in nonmetastatic castration-resistant prostate cancer.

Dr. Heath on Recent Approvals in Nonmetastic Prostate Cancer

January 09, 2020

Video

Elisabeth I. Heath, MD, FACP, discusses apalutamide, enzalutamide, and darolutamide, which have all been approved for use in nonmetastatic castration-resistant prostate cancer.

Dr. Heath on the Toxicity Profiles of Oral Antiandrogens in Nonmetastatic CRPC

January 03, 2020

Video

Elisabeth I. Heath, MD, FACP, discusses the safety profiles of apalutamide, enzalutamide, and darolutamide in nonmetastatic castration-resistant prostate cancer.

x